Cavanagh Bethany J

Track

Insider profile

Cavanagh Bethany J's trades of Beam Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Planned sale
Price
296.46
Quantity 51,681 -14.4%
Value US$136,195
Transaction date
Planned sale
Price
332.75
Quantity 97,249 +35.0%
Value US$2,385,152
Transaction date
Planned sale
Price
264.01
Quantity 23,275 +6.7%
Value US$2,158,342
Transaction date
Planned sale
Price
35.00
Quantity 6,287 -14.3%
Value US$220,045
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-04-06 2026-04-01
PlS Planned sale
51,681 -14.4%
296.46
US$136,195 		51,681 -14.4% 296.46 US$136,195
2026-01-26 2026-01-22
PlS Planned sale
97,249 +35.0%
332.75
US$2,385,152 		97,249 +35.0% 332.75 US$2,385,152
2026-01-21 2026-01-20
PlS Planned sale
23,275 +6.7%
264.01
US$2,158,342 		23,275 +6.7% 264.01 US$2,158,342
2025-10-03 2025-10-01
PlS Planned sale
467 -1.0%
24.53
US$11,456 		467 -1.0% 24.53 US$11,456
2025-04-03 2025-04-01
PlS Planned sale
3,015 -6.3%
18.35
US$55,330 		3,015 -6.3% 18.35 US$55,330
2025-02-20 2025-02-18
PlS Planned sale
6,287 -14.3%
35.00
US$220,045 		6,287 -14.3% 35.00 US$220,045
2025-01-06 2025-01-02
PlS Planned sale
1,117 -2.5%
24.68
US$27,568 		1,117 -2.5% 24.68 US$27,568
2024-12-30 2024-12-31
PrS Proposed sale
9,500
25.27
US$240,065 		9,500 25.27 US$240,065
2024-10-02 2024-10-01
PlS Planned sale
289 -0.6%
23.48
US$6,785 		289 -0.6% 23.48 US$6,785